Ⅱ
1934 Bull. Chem. Soc. Jpn., 74, No. 10 (2001)
Oxidative Addition to Ru (C5Me5)(amidinate)
2a: yellow microcrystals. 1H NMR (CDCl3) δ 1.23 (d, J =
7.0 Hz, 6H, CH(CH3)2), 1.30 (d, J = 7.0 Hz, 6H, CH(CH3)2), 1.79
(s, 15H, C5(CH3)5), 1.92 (s, 3H, CCH3), 2.32 (d, J = 10.1 Hz,, 2H,
anti-CH of the allyl group), 3.22 (sep, J = 7.0 Hz, 2H, CH(CH3)2),
4.03 (d, J = 6.0 Hz, 2H, syn-CH of the allyl group), 4.94 (dt, J =
6.0 Hz, 10.1, 1H, central-CH of the allyl group). 13C{1H}NMR
(CDCl3) δ 10.3 (C5(CH3)5), 22.5 (CCH3), 25.7, 26.1 (CH(CH3)2),
51.1 (CH(CH3)2), 60.8 (CH2 of the allyl group), 98.6 (CH of the
allyl group), 104.9 (C5(CH3)5), 174.3 (NCN).
2a-PF6: Orange crystals. Anal. Calcd for C21H37F6N2PRu: C,
44.76; H, 6.62; N, 4.97%. Found: C, 44.75; H, 6.58; N, 4.90%. 1H
NMR (in CDCl3) δ 1.22 (d, J = 7.0 Hz, 6H, CH(CH3)2), 1.29 (d, J
= 7.0 Hz, 6H, CH(CH3)2), 1.71 (s, 15H, C5(CH3)5), 1.90 (s, 3H,
CCH3), 2.09 (d, J = 10.3 Hz,, 2H, anti-CH of the allyl group),
3.20 (sep, J = 7.0 Hz, 2H, CH(CH3)2), 4.00 (d, J = 6.1 Hz,, 2H,
syn-CH of the allyl group), 4.93 (dt, J = 6.1 Hz,, 10.3, 1H, cen-
tral-CH of the allyl group). 13C{1H} NMR (CDCl3) δ 9.8
(C5(CH3)5), 22.4 (CCH3), 25.6 (CH(CH3)2), 25.9 (CH(CH3)2),
51.0 (CH(CH3)2), 60.2 (CH2 of the allyl group), 98.3 (CH of the
allyl group), 104.9 (C5(CH3)5), 174.3 (NCN). IR (KBr,) 3422,
2979, 2932, 1520, 1485, 1457, 1214, 1140, 839cm−1. mp: 138 °C
(dec.).
(CH of the allyl group), 106.7 (C5(CH3)5), 127.5, 127.6, 127.9,
129.9, 132.7, 138.6 (C6H5), 178.9 (NCN). IR (KBr) 3421, 3005,
2965, 1437, 1395, 1360, 1289, 2207, 1182, 1048, 954, 880, 802,
751, 718 cm−1. mp: 160 °C (dec.).
1
4a: Yellow microcrystals. H NMR (CDCl3) δ 1.20 (d, J =
7.0 Hz, 6H, CH(CH3)2), 1.24 (d, J = 7.0 Hz, 6H, CH(CH3)2), 1.71
(s, 15H, C5(CH3)5), 1.90 (s, 3H, CCH3), 2.07 (s, 3H, CH3 of the
methallyl group), 2.18 (s, 2H, anti-CH of the methallyl group),
3.13 (sep, J = 7.0 Hz, 2H, CH(CH3)2), 3.58 (s, 2H, syn-CH of the
methallyl group). 13C{1H} NMR (in CDCl3) δ 10.2 (C5(CH3)5),
17.6 (CH3 of the methallyl group), 22.8 (CCH3), 24.6 (CH(CH3)2),
26.0 (CH(CH3)2), 50.3 (CH(CH3)2), 58.3 (CH2 of the allyl group),
104.6 (C5(CH3)5), 113.1 (CH of the allyl group), 172.2 (NCN).
4a-PF6: Yellow microcrystals. Anal.
Calcd for
C22H39F6N2PRu: C, 45.75; H, 6.81; N, 4.85%. Found: C, 45.84;
H, 6.76; N, 4.82%. 1H NMR (CDCl3) δ 1.23 (d, J = 7.0 Hz, 6H,
CH(CH3)2), 1.27 (d, J = 7.0 Hz, 6H, CH(CH3)2), 1.68 (s, 15H,
C5(CH3)5), 1.92 (s, 3H, CCH3), 2.05 (s, 2H, anti-CH of the methal-
lyl group), 2.10 (s, 3H, CH3 of the methallyl group), 3.16 (sep, J
= 7.0 Hz, 2H, CH(CH3)2), 3.60 (s, 2H, syn-CH of the methallyl
group). 13C{1H} NMR (CDCl3) δ 9.8 (C5(CH3)5), 17.5 (CH3 of
the methallyl group), 22.8 (CCH3), 24.6 (CH(CH3)2), 26.0
(CH(CH3)2), 50.3 (CH(CH3)2), 58.0 (CH2 of the allyl group),
104.6 (C5(CH3)5), 113.0 (CH of the allyl group), 172.3 (NCN). IR
3a: Yellow microcrystals. 1H NMR (CDCl3) δ 1.21 (d, J =
7.0 Hz, 6H, CH(CH3)2), 1.28 (d, J = 7.0 Hz, 6H, CH(CH3)2), 1.76
(s, 15H, C5(CH3)5), 1.81 (s, 3H, CCH3), 2.25 (d, J = 10.1 Hz,, 2H,
anti-CH of the allyl group), 3.20 (sep, J = 7.0 Hz, 2H, CH(CH3)2),
4.01 (d, J = 6.0 Hz,, 2H, syn-CH of the allyl group), 4.92 (dt, J =
6.0 Hz,, 10.1, 1H, central-CH of the allyl group). 13C{1H} NMR
(CDCl3) δ 10.2 (C5(CH3)5), 22.4 (CCH3), 25.6 (CH(CH3)2), 25.9
(CH(CH3)2), 51.0 (CH(CH3)2), 60.6 (CH2 of the allyl group), 98.4
(CH of the allyl group), 104.8 (C5(CH3)5), 174.2 (NCN).
(KBr) 2981, 1519, 1489, 1384, 1337, 1213, 1138, 843, 557 cm−1
mp: 184 °C (dec.).
.
4b: Yellow microcrystals. 1H NMR (CDCl3) δ 0.91 (s, 18H,
C(CH3)3), 1.82 (s, 15H, C5(CH3)5), 2.40 (s, 2H, anti-CH of the
methallyl group), 2.41 (s, 3H, CH3 of the methallyl group), 4.06
(s, 2H, syn-CH of the methallyl group), 7.15–7.40 (m, 5H, C6H5).
13C{1H} NMR (in CDCl3) δ 11.3 (C5(CH3)5), 18.2 (CH3 of the
methallyl group), 35.6 (C5(CH3)5), 57.0 (C(CH3)3), 58.5 (CH2 of
the methallyl group), 106.1 (C5(CH3)5), 112.8 (central-C of the
methallyl group), 127.0, 127.3, 128.2, 129.8, 133.1, 137.9 (C6H5),
177.2 (NCN).
2b: Yellow microcrystals. 1H NMR (CDCl3) δ 0.95 (s, 18H,
C(CH3)3), 1.90 (s, 15H, C5(CH3)5), 2.51 (d, J = 10.4 Hz, 2H, anti-
CH of the allyl group), 4.59 (d, J = 6.3 Hz, 2H, syn-CH of the al-
lyl group), 5.36 (dt, J = 6.3 Hz, 10.4, 1H, central-CH of the allyl
group), 7.14 (m, 1H, C6H5), 7.24 (m, 1H, C6H5), 7.31 (m, 1H,
C6H5), 7.36 (m, 1H, C6H5), 7.44 (m, 1H, C6H5). 13C{1H} NMR (in
CDCl3) δ 11.4 (C5(CH3)5), 35.5 (C(CH3)3), 58.0 (C(CH3)3), 60.4
(CH2 of the allyl group), 97.4 (CH of the allyl group), 106.5
(C5(CH3)5), 127.5, 127.6, 127.8, 130.0, 132.6, 138.6 (C6H5), 179.2
(NCN).
4b-PF6: Orange crystals. Anal. Calcd for C29H45F6N2PRu:
C, 52.16; H, 6.79; N, 4.20%. Found: C, 52.31; H, 6.80; N, 4.26%.
1H NMR (CDCl3) δ 0.96 (s, 18H, C(CH3)3), 1.79 (s, 15H,
C5(CH3)5), 2.28 (s, 2H, anti-CH of the methallyl group), 2.46 (s,
3H, CH3 of the methallyl group), 4.06 (s, 2H, syn-CH of the meth-
allyl group), 7.21 (m, 1H, C6H5), 7.25 (m, 1H, C6H5), 7.32 (m, 1H,
C6H5), 7.34 (m, 1H, C6H5), 7.43 (m, 1H, C6H5). 13C{1H} NMR
(CDCl3) δ 11.0 (C5(CH3)5), 18.3 (CH3 of the methallyl group),
35.7 (C5(CH3)5), 57.1 (C(CH3)3), 58.1 (CH2 of the methallyl
group), 106.6 (C5(CH3)5), 112.5 (central-C of the methallyl
group), 127.2, 127.3, 128.4, 129.9, 133.4, 138.2 (C6H5), 177.1
2b-PF6: Orange crystals. Anal. Calcd for C28H43F6N2PRu: C,
1
51.45; H, 6.63; N, 4.29%. Found: C, 51.22; H, 6.62; N, 4.34%. H
NMR (CDCl3) δ 0.95 (s, 18H, C(CH3)3), 1.81 (s, 15H, C5(CH3)5)),
2.22 (d, J = 10.2 Hz,, 2H, anti-CH of the allyl group), 4.53 (d, J =
6.1 Hz,, 2H, syn-CH of the allyl group), 5.36 (dt, J = 6.1 Hz,,
10.2, 1H, central-CH of the allyl group), 7.16 (m, 1H, C6H5), 7.24
(m, 1H, C6H5), 7.32 (m, 1H, C6H5), 7.35 (m, 1H, C6H5), 7.44 (m,
1H, C6H5). 13C{1H} NMR (CDCl3) δ 10.9 (C5(CH3)5), 35.5
(C(CH3)3), 58.0 (C(CH3)3), 59.7 (CH2 of the allyl group), 97.2
(CH of the allyl group), 106.6 (C5(CH3)5), 127.4, 127.6, 127.8,
129.9, 132.8, 138.6 (C6H5), 178.9 (NCN). IR (KBr) 3437, 2966,
1442, 1208, 1183, 840 cm−1. mp: 164 °C (dec.).
(NCN). IR (KBr) 3437, 3001, 2966, 1439, 1207, 1183, 842 cm−1
.
mp: 184 °C (dec.).
5a: Yellow microcrystals. 1H NMR (CDCl3) δ 0.47 (d, J =
7.0 Hz, 3H, CH(CH3)2), 0.98 (d, J = 7.0 Hz, 3H, CH(CH3)2), 1.32
(d, J = 7.0 Hz, 3H, CH(CH3)2), 1.33 (d, J = 7.0 Hz, 3H,
CH(CH3)2), 1.83 (s, 3H, CCH3), 1.84 (s, 15H, C5(CH3)5), 2.27
(sep, J = 7.0 Hz, 1H, CH(CH3)2), 2.52 (d, J = 9.8 Hz, 1H, CHH
(anti)), 3.18 (sep, J = 7.0 Hz, 1H, CH(CH3)2), 4.16 (d, J = 6.1 Hz,
1H, CHH (syn)), 4.28 (d, J = 10.8 Hz, 1H, CHPh), 5.62 (ddd, J =
6.1, 9.8, 10.8 Hz, 1H, CH2CH), 7.29–7.42 (m, 5H, Ph). 13C{1H}
NMR (in CDCl3) δ 10.4 (C5(CH3)5), 23.6 (CCH3), 24.8, 25.7,
26.2, 26.7 (CH(CH3)2), 47.7, 50.4 (CH(CH3)2), 60.0 (CH2 of the
cinnamyl group), 86.0 (CHPh of the cinnamyl group), 95.6
(CH2CH of the cinnamyl group), 104.6 (C5(CH3)5), 128.6, 129.3,
129.6, 136.9 (Ph), 173.8 (NCN).
2b-BF4: Orange crystals. Anal. Calcd for C28H43BF4N2Ru: C,
56.47; H, 7.28; N, 4.70%. Found: C, 56.00; H, 7.24; N, 4.70%. 1H
NMR (CDCl3) δ 0.94 (s, 18H, C(CH3)3), 1.82 (s, 15H, C5(CH3)5),
2.42 (d, J = 10.4 Hz, 2H, anti-CH of the allyl group), 4.54 (d, J =
6.1, 2H, syn-CH of the allyl group), 5.36 (dt, J = 6.1, 10.4 Hz,
1H, central-CH of the allyl group), 7.15 (m, 1H, C6H5), 7.25 (m,
1H, C6H5), 7.31 (m, 1H, C6H5), 7.35 (m, 1H, C6H5), 7.43 (m, 1H,
C6H5).
(C(CH3)3), 58.0 (C(CH3)3), 59.7 (CH2 of the allyl group), 97.2
13C{1H} NMR (CDCl3) δ 11.0 (C5(CH3)5), 35.5
5a-PF6: Yellow microcrystals. Anal.
Calcd for